Loxo posts Phase 3 pirtobrutinib results; five more Lilly-linked trials updateSep 25Weekly roundup, 6 itemsabemaciclibbrenipatide
FDA approves supplemental application for Eli Lilly's InluriyoSep 18Regulatory decisionEli Lillyimlunestrant
Sign inSign in